Who bought what, at what price, and what it means whichever side of the table you sit. Compiled from the daily monitoring behind the Zoo, for practice owners weighing their position and buyers building a pipeline.
Australian general practice M&A re-rated between November 2025 and June 2026. Both sides of the market should reset their assumptions.
Insurers are now the marginal price-setter for GP platforms. The two largest GP platform deals of the past two years are both insurer-funded, private equity is exiting rather than rolling forward, and a reported ~$1bn ForHealth process would put two of the three largest GP corporate operators in insurer hands by the end of 2027. The review reads each move from the owner's side and the buyer's side, because the same fact prices differently depending on which side you are on.
The same market picture buyers work from, because information asymmetry is what this market's intermediaries sell. What the platform premiums do and do not mean for your practice, which attributes move price at your scale, and why the CGT changes give the decision a date.
Where competitive tension now comes from, what the notification regime does to serial acquisition, which operators are adding sites and which are exiting, and the counterparty structure below the platform tier where most transactions clear.
Owners: a confidential register. Location band, size band, timeframe, what you want. Not a listing, no fee, no obligation, nothing moves without your instruction.
Buyers: a standing acquisition brief. Register your criteria and Medius watches the operator dataset, the transaction record and the independent practice lists for fits.
More from the Zoo: the Zoo scan, daily · the operator dashboard · licence the data.